Testing grape powder in adults with obesity on gut and immune health
Compares freeze-dried grape powder with placebo powder in adults with obesity, ages 18 to 60.
Key facts
- Who runs it
- University of Missouri-Columbia
- Where
- Columbia, United StatesSee the site
- Trial code
- Registry title
- Effects of Grape Consumption on the Immune-Gut Axis in Obesity
- Status
- Recruiting
- People taking part
- 50 people, planned
- Started
- 19 Dec 2025
- Expected to end
- 30 Dec 2027
- Type of study
- Interventional, 2 groups
- Treatments tested
- Freeze-dried grape powder
- Placebo powder
- Record updated
- 31 July 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 18-60 with obesity (BMI of 30-45 kg/m2) who are willing to eat the study foods, including a freeze-dried grape powder.
- Age
- 18 to 60 years
- Sex
- All sexes can join.
- Disease stage
- Obesity with a BMI of 30-45 kg/m2.
- Earlier treatment
- Weight must be stable (less than 5kg (11 lb (5 kg)) change over the last 3 months). Diet and activity must be consistent for 4 weeks. No recent antibiotics, prebiotics, probiotics, symbiotics or fiber supplements.
Main reasons for not taking part
- Diabetes
- Gastrointestinal disease or bariatric surgery
- Uncontrolled hypertension with blood pressure over 180/110
- Pregnant or breastfeeding
- HIV positivity
The registry criteria, word for word
Show all 20 criteriaShow less
Who can take part
- Age: 18-60 years
- Obesity with BMI of 30-45 kg/m2
- Willingness to consume study foods
- Consistent diet and activity patterns for 4 weeks
- Weight stable (<5kg change over last 3 months)
- Non-smoker > 1 year or more
- Not currently consuming an extremely healthy diet
Who cannot take part
- Illicit drug use
- Recent use of medications that affect immune function (e.g., corticosteroids)
- Recent start of medications that affect metabolism or appetite
- Study food allergies
- Gastrointestinal disease and/or bariatric surgery
- Uncontrolled hypertension and blood pressure >180/110
- Diabetes
- History of alcohol or drug abuse
- HIV positivity
- Drug therapy for coronary artery disease, peripheral artery disease, congestive
- Regular consumption of grapes or grape-derived products
- Recent consumption of antibiotics, prebiotics, probiotics, symbiotics, or dietary supplements containing fiber or phytochemicals
- Pregnant or lactating individuals
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 60 years old?
Where in United States
- University of Missouri - ColumbiaColumbia, United StatesContact: Caitlyn Winn, MSTaking people
About the trial
What the trial wants to find out
This study is investigating the benefits of whole freeze-dried grape powder consumption on the immune-gut axis in adults with obesity.
The 2 groups in the trial
- Sequence 1: Grape then PlaceboTreatment being tested
Whole freeze-dried grape powder for 4 weeks, 4-week washout, then isocaloric placebo powder for 4 weeks.
Treatment: Freeze-dried grape powder and Placebo powder
- Sequence 2: Placebo then GrapeTreatment being tested
Isocaloric placebo powder for 4 weeks, 4-week washout, then whole freeze-dried grape powder for 4 weeks.
Treatment: Freeze-dried grape powder and Placebo powder
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Effects of Grape Consumption on Immune and Gut Health in the Setting of Obesity
- Plain-language title
- Testing grape powder in adults with obesity on gut and immune healthGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT07231484, who can take part
- Record updated
- 31 July 2026